This next post and the one folloing were both deleted , but

New Post Public Reply Private Reply Replies (0) Message Board
Pafiddler
527
This next post and the one folloing were both deleted , but I think brought up some important concerns:

****
I'm very concerned because the media is stressing the need for vaccinations as if it's a "cure-all!"

People are rightly confused and frustrated...

And most aren't avidly watching the world as Covid sweeps through different populations and creates terrifying new variants that will make mincemeat of our unprepared and oblivious population.

And meanwhile the FDA will not approve or grant an EUA to the only drug that stands a chance to help AND should already be in the process of mass production as I write this.

Even if approved, due to the FDA's CRIMINAL delay, there's no where near enough to go around! So the next question will be who gets and who doesn't.

And do YOU think it's going to just ANYBODY. Be prepared for a serious revolt from a maddened populace.

You want to see chaos - the FDA is helping to prepare the stage for a massive upheaval of civil discontent!

Sorrowfully written - so sad and the pile of dead will grow exponentially and civil unrest will not be a picnic either.

FDA reconsider your position and the best interests of our country while you can!!! There still might be time - but not much. We need approval ASAP and production of Leronlimab ramped up immediately!!!


IMO

****

Oh, well - the above was off topic

And here was the follow up post

****
et the former post sink in...

This is big trouble for everyone. I remember Mussolini and his lady "hanging around" after the Italians surrendered. Not a pretty picture...and I don't want to see it here involving my fellow citizens.
With adequate preparation and planning we can avoid this situation. But we have to contend with those that cannot see reality through their haze of greed.

We desperately need Leronlimab approved and in massive production NOW

NOW
NOW
NOW!!!!!!!


NOT JUST MY OPINION BUT A REPLAY OF HISTORY THAT WE DON'T WANT!!

****
Okay not wanting to waste your time, but as an avid supporter of Leronlimab (and a very old person) I don't have a lot of time to put up with the foolishness encountered on Ihub. What I mentioned in the last two posts above is a real concern.

If and when Leronlimab is approved are YOU and ME going to be able to get some from the very limited supply? Or is it going to be handed out to only the select insiders? This could be a very contentious affair and when people you care about are dying while others are flaunting their good fortune>>> I can't picture a good outcome.


Thank you for your tolerance. Learning53/PAfiddler

CytoDyn Inc (CYDY) Stock Research Links

CYDY Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Cannabis Industry Pushes for Robust Financial Services

Updated Category News Views 3

Industry Gears Up for Financial Action Clearly, cannabis businesses are shouting louder than a vendor at a ballgame, demanding more than just the basic chips-and-soda banking service. They’re on the hunt for serious credit facilities, payments, and the traditional financial tools that most sectors take for granted. I mean, check this out: Shield Compliance just dropped...

Continue Reading
Sandbox VR Expands to Melbourne, Betting on Immersive Fun

Updated Category News Views 3

Sandbox VR Ventures into Melbourne's Heart Every now and then, a venture takes its ambitions and rolls the dice on a prime location. Sandbox VR is swaggering into Melbourne's bustling Central Business District, fresh out of its success on the Gold Coast. Opening this Melbourne venue on September 14 marks a significant leap in the company's Aussie expansion—a bold nod to...

Continue Reading
GBI Bio's New CEO Jesse McCool to Propel Growth

Updated Category News Views 1

Jesse McCool stepping into GBI's CEO shoes is the kind of move that makes you sit up straight and take notice. Let me tell you, the biomanufacturing scene is buzzing with this appointment, and McCool's got his work cut out for him in leading GBI Biomanufacturing's shift towards commercial-scale operations while expanding their early-stage biotech portfolio. A Veteran in...

Continue Reading
Cap Juluca: Caribbean Luxury Redefined on Maundays Bay

Updated Category News Views 2

The Tranquil Call of Maundays Bay Find me dipping my toes in the sands of Maundays Bay come October 10, 2026, and you'll understand why this slice of Anguilla stakes its claim to being the best beach on the globe. Cap Juluca, that crown jewel of Caribbean luxury, swings open its doors once more, promising indulgence framed by turquoise waters and the soft whisper of white...

Continue Reading
WNET's 25th Anniversary 9/11 Tribute: Stories and Lessons

Updated Category News Views 3

Reflecting on a Dark Day with WNET's Programming Nothing quite hits you like the anniversary of a colossal tragedy. The memories of September 11, 2001, remain etched in the urban landscape of New York City, and this year marks 25 years since that heart-wrenching day. The WNET Group steps up to the plate with a comprehensive slate of programming aimed at honoring the...

Continue Reading
Shareholder Rights in Focus: Examining Key Buyouts

Updated Category News Views 4

Shareholder Concerns Rise Amid Corporate Buyouts The stakes are high for the shareholders of Distribution Solutions Group, Eagle Financial Services, Safety Insurance Group, and Utz Brands as their companies face potential buyouts. Let's chew over what's on the table: the sweet deals insiders might score and the legal maneuvers in play. Halper Sadeh LLC, a heavy-hitting...

Continue Reading
Unpacking RAGEism: Power Dynamics in U.S. Policies

Updated Category News Views 1

Seeing Patterns in Crisis: Jackson and Flint When Jackson, Mississippi's latest water crisis hit the news, it wasn't the first time folks were left high and dry. No, this fiasco's got deep roots, and it resonates with another infamous case: Flint, Michigan. In Maya Rockeymoore Cummings' book, RAGEism, these are badge-worthy examples of 'Resource Hoarding' where government...

Continue Reading
Diaper Affordability: A Hidden Crisis, Taxpayer Burden

Updated Category News Views 4

A Silent Crisis Lurking in Diapers Diapers. We don’t think about them much until we need them, but nearly half of U.S. families are painfully aware of their cost. According to a report from the NDBN Diaper Check 2026, many struggle to meet this basic necessity. This isn't just about keeping babies clean—it's a public health issue with economic ripples Congress can't...

Continue Reading
AbbVie's Bold Leap in Menstrual Migraine Treatment

Updated Category News Views 1

AbbVie's Game-Changing Atogepant Study When it comes to pushing boundaries in the pharmaceutical world, there's no sitting on the fence. AbbVie's Phase 3 LUNA study results are painting a bright picture for women who suffer from the relentless grip of menstrual migraines. In a world where not a single treatment option has been approved specifically for this condition,...

Continue Reading
Rare Collectibles Highlight Morphy's Auction on Oct 4

Updated Category News Views 1

Anticipation Builds for Morphy's Auction Event Morphy's upcoming event on October 4th is all about tapping into the era of revved engines, gleaming gasoline signs, and some history that could put Hollywood tales to shame. The auction isn't just a stroll down memory lane; it features over 650 lots, each a time capsule of America's automotive past. From Al Capone's ritzy...

Continue Reading

Top 5 Most Recently Viewed Articles

Global Liver Biopsy Market to Surge with Innovative Techniques

Updated Category News Views 175

Understanding the Growth of the Liver Biopsy Market The liver biopsy market demonstrates robust growth, projected to reach USD 1.65 billion. A recent report highlights that in 2023, the market valuation stood at approximately USD 0.90 billion. This significant increase is primarily attributed to the rising incidences of liver diseases and advancements in biopsy...

Continue Reading
CarParts.com to Showcase Innovations at Key Investment Event

Updated Category News Views 123

CarParts.com to Showcase Innovations at Key Investment Event CarParts.com, Inc. (NASDAQ: PRTS), a leading e-commerce provider of automotive parts and accessories, is excited to announce its presence at the 19th annual LD Micro Main Event. This highly anticipated event will be held at the picturesque Hotel del Coronado in San Diego. Ryan Lockwood, the Chief Financial...

Continue Reading
Sabina Adamski Introduces Her New Lending Team at Guaranteed Rate Affinity

Updated Category News Views 138

The Launch of The Sabina Adamski Group In a transformative move within the mortgage sector, Sabina Adamski has officially launched The Sabina Adamski Group following her return to Guaranteed Rate Affinity as Vice President of Mortgage Lending. This new initiative aims to provide a modern, client-first approach tailored for homebuyers. Expanding Reach and Enhancing...

Continue Reading
Innovative Sepsis Treatment STC3141 Hits Clinical Milestone

Updated Category News Views 308

Breakthrough Achievement for Grand Pharma's STC3141 Grand Pharmaceutical Group Limited has proudly announced a significant milestone in medical research with its innovative drug, STC3141, successfully reaching the clinical endpoint in a Phase II clinical study aimed at treating sepsis. This impressive achievement highlights not only the Group's commitment to pioneering...

Continue Reading
Vera Bradley's Fiscal Q2 Results Highlight Future Growth Plans

Updated Category News Views 176

Overview of Vera Bradley's Recent Financial Performance Vera Bradley, Inc. (Nasdaq: VRA) has shared its financial results for the second quarter of the fiscal year 2025, showing a consolidated net revenue of $110.8 million. While this marks a drop from $128.2 million from the same time last year, the company remains hopeful about its future direction. Key Financial...

Continue Reading